Trial Profile
The effects of testosterone supplementation on functional mobility, quality of life, body composition, cognitive function, aortic stiffness and cardiovascular risk factors, and bone mineral density in ageing men with an age-related decline of testosterone [testosterone undecanoate]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2011
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hormone deficiency
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms ELIQSOR
- 01 Apr 2011 Outcomes on the Androgen Deficiency in Ageing Male and the Ageing Males' Symptoms rating scale questionnaires published in Clinical Endocrinology.
- 02 May 2009 New source identified and integrated (Netherlands Trial Register).
- 02 Jan 2008 Results published in JAMA.